Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: IRD – NASDAQ
Animal Usage: Animal Testing
Opus Genetics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company confirms in corporate disclosures that it utilizes animal subjects for product testing.
“Restoration of the RPE-photoreceptor interface was demonstrated in the treated animals, including resolution of the retinal microdetachments.” Read the article for more details
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs). The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Durham, North Carolina.
Company Website: https://www.opusgtx.com